OmniAb (OABI) Capital Expenditures (2022 - 2026)
OmniAb (OABI) reported Capital Expenditures of $167000.0 for Q1 2026, down 20.1% year-over-year from $209000.0 in Q1 2025, and up 1755.56% quarter-over-quarter from $9000.0 in Q4 2025.
OmniAb (OABI) Capital Expenditures (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Capital Expenditures data on file, last reported at $167000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $167000.0, down 20.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $523000.0 (up 393.82% YoY), and the FY2025 annual result was $565000.0, up 633.77% from the prior year.
- Capital Expenditures grew to $167000.0 in Q1 2026 per OABI's latest filing, from $9000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $2.5 million in Q1 2022 and troughed at -$3.5 million in Q4 2022.
- A 5-year average of $88117.6 and a median of $182000.0 in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures plunged 2447.5% in 2023, then soared 264.28% in 2024.
- A 5-year view of Capital Expenditures shows it stood at -$3.5 million in 2022, then soared by 118.06% to $639000.0 in 2023, then tumbled by 374.18% to -$1.8 million in 2024, then soared by 100.51% to $9000.0 in 2025, then jumped by 1755.56% to $167000.0 in 2026.
- Business Quant data shows OABI's Capital Expenditures at $167000.0 in Q1 2026, $9000.0 in Q4 2025, and $182000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 167,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167,000.00 |
| Mar 31, 2026 | 167,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 182,000.00 |
| Sep 30, 2025 | 182,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Dec 31, 2024 | -1.75 Mn |
| Dec 31, 2024 | -1.75 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | -309,000.00 |
| Jun 30, 2024 | -309,000.00 |
| Mar 31, 2024 | 464,000.00 |
| Mar 31, 2024 | 464,000.00 |
| Dec 31, 2023 | 639,000.00 |
| Dec 31, 2023 | 639,000.00 |